nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE2—bile—pancreatic cancer	0.0872	0.574	CbGeAlD
Lisinopril—ABCB1—Tamoxifen—pancreatic cancer	0.0687	0.199	CbGbCtD
Lisinopril—ABCB1—Gemcitabine—pancreatic cancer	0.0592	0.172	CbGbCtD
Lisinopril—ABCB1—Erlotinib—pancreatic cancer	0.0584	0.169	CbGbCtD
Lisinopril—ABCB1—Irinotecan—pancreatic cancer	0.0527	0.153	CbGbCtD
Lisinopril—ABCB1—Docetaxel—pancreatic cancer	0.0386	0.112	CbGbCtD
Lisinopril—ABCB1—Sunitinib—pancreatic cancer	0.0385	0.112	CbGbCtD
Lisinopril—ABCB1—Doxorubicin—pancreatic cancer	0.0288	0.0835	CbGbCtD
Lisinopril—ACE2—gall bladder—pancreatic cancer	0.0242	0.159	CbGeAlD
Lisinopril—ACE—umbilical vein—pancreatic cancer	0.0192	0.127	CbGeAlD
Lisinopril—ACE2—digestive system—pancreatic cancer	0.00952	0.0627	CbGeAlD
Lisinopril—SLC15A1—digestive system—pancreatic cancer	0.00434	0.0286	CbGeAlD
Lisinopril—ACE—digestive system—pancreatic cancer	0.00311	0.0205	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR1—pancreatic cancer	0.0024	0.199	CbGpPWpGaD
Lisinopril—ABCB1—islet of Langerhans—pancreatic cancer	0.00183	0.012	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.00132	0.11	CbGpPWpGaD
Lisinopril—ABCB1—pancreas—pancreatic cancer	0.00128	0.00846	CbGeAlD
Lisinopril—ABCB1—digestive system—pancreatic cancer	0.0011	0.00722	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR1—pancreatic cancer	0.00107	0.089	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—pancreatic cancer	0.00082	0.0681	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—GCG—pancreatic cancer	0.000695	0.0577	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.000591	0.049	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—FUT8—pancreatic cancer	0.000409	0.0339	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—pancreatic cancer	0.000366	0.0304	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—GCG—pancreatic cancer	0.00031	0.0258	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.00028	0.0233	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000262	0.0217	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—PCSK1—pancreatic cancer	0.00025	0.0207	CbGpPWpGaD
Lisinopril—Chest pain—Docetaxel—pancreatic cancer	0.000249	0.000506	CcSEcCtD
Lisinopril—Nausea—Sunitinib—pancreatic cancer	0.000249	0.000506	CcSEcCtD
Lisinopril—Pancytopenia—Doxorubicin—pancreatic cancer	0.000248	0.000506	CcSEcCtD
Lisinopril—Renal failure—Epirubicin—pancreatic cancer	0.000248	0.000504	CcSEcCtD
Lisinopril—Asthenia—Irinotecan—pancreatic cancer	0.000247	0.000504	CcSEcCtD
Lisinopril—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000247	0.000503	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000247	0.000503	CcSEcCtD
Lisinopril—Jaundice—Epirubicin—pancreatic cancer	0.000246	0.0005	CcSEcCtD
Lisinopril—Urinary tract infection—Epirubicin—pancreatic cancer	0.000245	0.000499	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—pancreatic cancer	0.000245	0.000498	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—pancreatic cancer	0.000245	0.000498	CcSEcCtD
Lisinopril—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000243	0.000495	CcSEcCtD
Lisinopril—Dry mouth—Docetaxel—pancreatic cancer	0.000243	0.000495	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000243	0.000495	CcSEcCtD
Lisinopril—Sweating—Epirubicin—pancreatic cancer	0.000242	0.000492	CcSEcCtD
Lisinopril—Asthenia—Gemcitabine—pancreatic cancer	0.000241	0.000491	CcSEcCtD
Lisinopril—Haematuria—Epirubicin—pancreatic cancer	0.00024	0.000489	CcSEcCtD
Lisinopril—Confusional state—Docetaxel—pancreatic cancer	0.00024	0.000489	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000239	0.000486	CcSEcCtD
Lisinopril—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000238	0.000485	CcSEcCtD
Lisinopril—Oedema—Docetaxel—pancreatic cancer	0.000238	0.000485	CcSEcCtD
Lisinopril—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000238	0.000485	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—pancreatic cancer	0.000238	0.000485	CcSEcCtD
Lisinopril—Epistaxis—Epirubicin—pancreatic cancer	0.000238	0.000484	CcSEcCtD
Lisinopril—Pruritus—Gemcitabine—pancreatic cancer	0.000238	0.000484	CcSEcCtD
Lisinopril—Infection—Docetaxel—pancreatic cancer	0.000237	0.000482	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—pancreatic cancer	0.000237	0.000482	CcSEcCtD
Lisinopril—Sinusitis—Epirubicin—pancreatic cancer	0.000236	0.000481	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000236	0.00048	CcSEcCtD
Lisinopril—Diarrhoea—Irinotecan—pancreatic cancer	0.000236	0.00048	CcSEcCtD
Lisinopril—Agranulocytosis—Epirubicin—pancreatic cancer	0.000235	0.000479	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—pancreatic cancer	0.000235	0.000478	CcSEcCtD
Lisinopril—Shock—Docetaxel—pancreatic cancer	0.000234	0.000477	CcSEcCtD
Lisinopril—Pruritus—Fluorouracil—pancreatic cancer	0.000234	0.000476	CcSEcCtD
Lisinopril—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000233	0.000475	CcSEcCtD
Lisinopril—Tachycardia—Docetaxel—pancreatic cancer	0.000233	0.000474	CcSEcCtD
Lisinopril—Skin disorder—Docetaxel—pancreatic cancer	0.000232	0.000471	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000231	0.000471	CcSEcCtD
Lisinopril—Bradycardia—Epirubicin—pancreatic cancer	0.00023	0.000469	CcSEcCtD
Lisinopril—Diarrhoea—Gemcitabine—pancreatic cancer	0.00023	0.000468	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—pancreatic cancer	0.000229	0.000467	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000229	0.000465	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000228	0.019	CbGpPWpGaD
Lisinopril—Dizziness—Irinotecan—pancreatic cancer	0.000228	0.000464	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—pancreatic cancer	0.000227	0.000463	CcSEcCtD
Lisinopril—Anorexia—Docetaxel—pancreatic cancer	0.000227	0.000462	CcSEcCtD
Lisinopril—Rhinitis—Epirubicin—pancreatic cancer	0.000227	0.000462	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000227	0.000461	CcSEcCtD
Lisinopril—Hepatitis—Epirubicin—pancreatic cancer	0.000226	0.000461	CcSEcCtD
Lisinopril—Diarrhoea—Fluorouracil—pancreatic cancer	0.000226	0.00046	CcSEcCtD
Lisinopril—Pharyngitis—Epirubicin—pancreatic cancer	0.000225	0.000457	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—pancreatic cancer	0.000224	0.000455	CcSEcCtD
Lisinopril—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000223	0.000455	CcSEcCtD
Lisinopril—Oedema peripheral—Epirubicin—pancreatic cancer	0.000223	0.000454	CcSEcCtD
Lisinopril—Hypotension—Docetaxel—pancreatic cancer	0.000223	0.000453	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—pancreatic cancer	0.000222	0.000453	CcSEcCtD
Lisinopril—Urethral disorder—Epirubicin—pancreatic cancer	0.000222	0.000452	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000221	0.000449	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—pancreatic cancer	0.00022	0.000448	CcSEcCtD
Lisinopril—Vomiting—Irinotecan—pancreatic cancer	0.000219	0.000446	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—pancreatic cancer	0.000219	0.000445	CcSEcCtD
Lisinopril—Dizziness—Fluorouracil—pancreatic cancer	0.000218	0.000445	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000218	0.000443	CcSEcCtD
Lisinopril—Rash—Irinotecan—pancreatic cancer	0.000217	0.000443	CcSEcCtD
Lisinopril—Dermatitis—Irinotecan—pancreatic cancer	0.000217	0.000442	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000217	0.000442	CcSEcCtD
Lisinopril—Headache—Irinotecan—pancreatic cancer	0.000216	0.00044	CcSEcCtD
Lisinopril—Insomnia—Docetaxel—pancreatic cancer	0.000216	0.000439	CcSEcCtD
Lisinopril—Paraesthesia—Docetaxel—pancreatic cancer	0.000214	0.000436	CcSEcCtD
Lisinopril—Erythema multiforme—Epirubicin—pancreatic cancer	0.000214	0.000436	CcSEcCtD
Lisinopril—Vomiting—Gemcitabine—pancreatic cancer	0.000214	0.000435	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—pancreatic cancer	0.000213	0.000434	CcSEcCtD
Lisinopril—Dyspnoea—Docetaxel—pancreatic cancer	0.000212	0.000433	CcSEcCtD
Lisinopril—Somnolence—Docetaxel—pancreatic cancer	0.000212	0.000431	CcSEcCtD
Lisinopril—Rash—Gemcitabine—pancreatic cancer	0.000212	0.000431	CcSEcCtD
Lisinopril—Dermatitis—Gemcitabine—pancreatic cancer	0.000212	0.000431	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—pancreatic cancer	0.000211	0.000429	CcSEcCtD
Lisinopril—Headache—Gemcitabine—pancreatic cancer	0.00021	0.000428	CcSEcCtD
Lisinopril—Flushing—Epirubicin—pancreatic cancer	0.00021	0.000427	CcSEcCtD
Lisinopril—Vomiting—Fluorouracil—pancreatic cancer	0.00021	0.000427	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—pancreatic cancer	0.00021	0.000427	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—pancreatic cancer	0.00021	0.000427	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—pancreatic cancer	0.000209	0.000426	CcSEcCtD
Lisinopril—Rash—Fluorouracil—pancreatic cancer	0.000208	0.000424	CcSEcCtD
Lisinopril—Dermatitis—Fluorouracil—pancreatic cancer	0.000208	0.000423	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—pancreatic cancer	0.000208	0.000423	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—pancreatic cancer	0.000207	0.000422	CcSEcCtD
Lisinopril—Headache—Fluorouracil—pancreatic cancer	0.000207	0.000421	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000207	0.000421	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000206	0.00042	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000206	0.000419	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—pancreatic cancer	0.000205	0.000418	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—pancreatic cancer	0.000205	0.000418	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—pancreatic cancer	0.000205	0.000418	CcSEcCtD
Lisinopril—Nausea—Irinotecan—pancreatic cancer	0.000205	0.000417	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000204	0.000415	CcSEcCtD
Lisinopril—Pain—Docetaxel—pancreatic cancer	0.000204	0.000415	CcSEcCtD
Lisinopril—Constipation—Docetaxel—pancreatic cancer	0.000204	0.000415	CcSEcCtD
Lisinopril—Chills—Epirubicin—pancreatic cancer	0.000203	0.000413	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—pancreatic cancer	0.000202	0.000411	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—pancreatic cancer	0.0002	0.000407	CcSEcCtD
Lisinopril—Nausea—Gemcitabine—pancreatic cancer	0.000199	0.000406	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—pancreatic cancer	0.000198	0.000404	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000198	0.000403	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—pancreatic cancer	0.000197	0.000401	CcSEcCtD
Lisinopril—Erythema—Epirubicin—pancreatic cancer	0.000197	0.000401	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—pancreatic cancer	0.000196	0.0004	CcSEcCtD
Lisinopril—Nausea—Fluorouracil—pancreatic cancer	0.000196	0.000399	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—pancreatic cancer	0.000195	0.000397	CcSEcCtD
Lisinopril—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000195	0.000397	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—pancreatic cancer	0.000194	0.000396	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—pancreatic cancer	0.000194	0.000395	CcSEcCtD
Lisinopril—Tension—Epirubicin—pancreatic cancer	0.000193	0.000393	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—pancreatic cancer	0.000193	0.000393	CcSEcCtD
Lisinopril—Nervousness—Epirubicin—pancreatic cancer	0.000191	0.000389	CcSEcCtD
Lisinopril—Back pain—Epirubicin—pancreatic cancer	0.000191	0.000388	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—pancreatic cancer	0.00019	0.000387	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—pancreatic cancer	0.000189	0.000385	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000189	0.000384	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—pancreatic cancer	0.000188	0.000384	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—pancreatic cancer	0.000188	0.000384	CcSEcCtD
Lisinopril—Chills—Doxorubicin—pancreatic cancer	0.000188	0.000382	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—pancreatic cancer	0.000187	0.000381	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—pancreatic cancer	0.000186	0.000378	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—pancreatic cancer	0.000185	0.000377	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—pancreatic cancer	0.000183	0.000373	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000183	0.000372	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—FUT8—pancreatic cancer	0.000183	0.0152	CbGpPWpGaD
Lisinopril—Malnutrition—Doxorubicin—pancreatic cancer	0.000182	0.000371	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—pancreatic cancer	0.000182	0.000371	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—pancreatic cancer	0.000182	0.000371	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—pancreatic cancer	0.00018	0.000366	CcSEcCtD
Lisinopril—Tension—Doxorubicin—pancreatic cancer	0.000179	0.000364	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—pancreatic cancer	0.000178	0.000363	CcSEcCtD
Lisinopril—Malaise—Epirubicin—pancreatic cancer	0.000178	0.000362	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—pancreatic cancer	0.000177	0.00036	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—pancreatic cancer	0.000177	0.00036	CcSEcCtD
Lisinopril—Syncope—Epirubicin—pancreatic cancer	0.000177	0.00036	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—pancreatic cancer	0.000176	0.000359	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—pancreatic cancer	0.000176	0.000359	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—pancreatic cancer	0.000176	0.000357	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—pancreatic cancer	0.000175	0.000357	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—pancreatic cancer	0.000174	0.000354	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—pancreatic cancer	0.000173	0.000352	CcSEcCtD
Lisinopril—Cough—Epirubicin—pancreatic cancer	0.000172	0.00035	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—pancreatic cancer	0.000172	0.00035	CcSEcCtD
Lisinopril—Asthenia—Docetaxel—pancreatic cancer	0.000171	0.000348	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000169	0.000344	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—pancreatic cancer	0.000169	0.000343	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—pancreatic cancer	0.000168	0.000343	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—pancreatic cancer	0.000168	0.000341	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—pancreatic cancer	0.000168	0.000341	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—pancreatic cancer	0.000168	0.000341	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—pancreatic cancer	0.000167	0.00034	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000167	0.000339	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—pancreatic cancer	0.000166	0.000337	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—pancreatic cancer	0.000164	0.000335	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—pancreatic cancer	0.000164	0.000334	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—pancreatic cancer	0.000164	0.000333	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—pancreatic cancer	0.000163	0.000333	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000163	0.0136	CbGpPWpGaD
Lisinopril—Leukopenia—Doxorubicin—pancreatic cancer	0.000163	0.000332	CcSEcCtD
Lisinopril—Diarrhoea—Docetaxel—pancreatic cancer	0.000163	0.000332	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—pancreatic cancer	0.000162	0.00033	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—pancreatic cancer	0.000161	0.000328	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000161	0.000327	CcSEcCtD
Lisinopril—Oedema—Epirubicin—pancreatic cancer	0.000161	0.000327	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00016	0.000326	CcSEcCtD
Lisinopril—Infection—Epirubicin—pancreatic cancer	0.00016	0.000325	CcSEcCtD
Lisinopril—Cough—Doxorubicin—pancreatic cancer	0.000159	0.000324	CcSEcCtD
Lisinopril—Shock—Epirubicin—pancreatic cancer	0.000158	0.000322	CcSEcCtD
Lisinopril—Dizziness—Docetaxel—pancreatic cancer	0.000158	0.000321	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000157	0.00032	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—pancreatic cancer	0.000157	0.000319	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—pancreatic cancer	0.000156	0.000318	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000155	0.000316	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—pancreatic cancer	0.000155	0.000316	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—pancreatic cancer	0.000155	0.000316	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—pancreatic cancer	0.000155	0.000316	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—pancreatic cancer	0.000155	0.000315	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000154	0.000314	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—pancreatic cancer	0.000153	0.000312	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—pancreatic cancer	0.000153	0.000312	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—pancreatic cancer	0.000152	0.000309	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—pancreatic cancer	0.000152	0.000308	CcSEcCtD
Lisinopril—Rash—Docetaxel—pancreatic cancer	0.00015	0.000306	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—pancreatic cancer	0.00015	0.000306	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—pancreatic cancer	0.00015	0.000306	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—pancreatic cancer	0.00015	0.000305	CcSEcCtD
Lisinopril—Headache—Docetaxel—pancreatic cancer	0.000149	0.000304	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000149	0.000303	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—pancreatic cancer	0.000149	0.000303	CcSEcCtD
Lisinopril—Infection—Doxorubicin—pancreatic cancer	0.000148	0.000301	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000146	0.000298	CcSEcCtD
Lisinopril—Shock—Doxorubicin—pancreatic cancer	0.000146	0.000298	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000146	0.000296	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—pancreatic cancer	0.000145	0.000296	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—pancreatic cancer	0.000145	0.000296	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—pancreatic cancer	0.000144	0.000294	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—pancreatic cancer	0.000144	0.000294	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000144	0.000293	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—pancreatic cancer	0.000143	0.000292	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—pancreatic cancer	0.000143	0.000291	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—pancreatic cancer	0.000142	0.000289	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000142	0.0118	CbGpPWpGaD
Lisinopril—Nausea—Docetaxel—pancreatic cancer	0.000142	0.000288	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—pancreatic cancer	0.000142	0.000288	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—pancreatic cancer	0.00014	0.000284	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—pancreatic cancer	0.000139	0.000283	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000139	0.000283	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—pancreatic cancer	0.000139	0.000282	CcSEcCtD
Lisinopril—Pain—Epirubicin—pancreatic cancer	0.000137	0.00028	CcSEcCtD
Lisinopril—Constipation—Epirubicin—pancreatic cancer	0.000137	0.00028	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000136	0.000276	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—pancreatic cancer	0.000135	0.000274	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—pancreatic cancer	0.000134	0.000272	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000133	0.0111	CbGpPWpGaD
Lisinopril—Dyspnoea—Doxorubicin—pancreatic cancer	0.000133	0.00027	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—pancreatic cancer	0.000132	0.00027	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—pancreatic cancer	0.000132	0.000269	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000131	0.000268	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—GCG—pancreatic cancer	0.000131	0.0109	CbGpPWpGaD
Lisinopril—Dyspepsia—Doxorubicin—pancreatic cancer	0.000131	0.000267	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—pancreatic cancer	0.000129	0.000263	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000128	0.000261	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—pancreatic cancer	0.000128	0.000261	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—pancreatic cancer	0.000128	0.00026	CcSEcCtD
Lisinopril—Pain—Doxorubicin—pancreatic cancer	0.000127	0.000259	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—pancreatic cancer	0.000127	0.000259	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—pancreatic cancer	0.000127	0.000259	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—pancreatic cancer	0.000127	0.000259	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000125	0.0104	CbGpPWpGaD
Lisinopril—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000123	0.00025	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000122	0.000248	CcSEcCtD
Lisinopril—Hypersensitivity—Epirubicin—pancreatic cancer	0.000118	0.000241	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—pancreatic cancer	0.000118	0.000241	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—pancreatic cancer	0.000118	0.000239	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—pancreatic cancer	0.000118	0.000239	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—pancreatic cancer	0.000115	0.000235	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—pancreatic cancer	0.000114	0.000232	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—PCSK1—pancreatic cancer	0.000112	0.00926	CbGpPWpGaD
Lisinopril—Diarrhoea—Epirubicin—pancreatic cancer	0.00011	0.000224	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00011	0.000223	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—pancreatic cancer	0.000107	0.000217	CcSEcCtD
Lisinopril—Dizziness—Epirubicin—pancreatic cancer	0.000106	0.000216	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—pancreatic cancer	0.000105	0.000214	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000104	0.0086	CbGpPWpGaD
Lisinopril—Vomiting—Epirubicin—pancreatic cancer	0.000102	0.000208	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000102	0.00847	CbGpPWpGaD
Lisinopril—Diarrhoea—Doxorubicin—pancreatic cancer	0.000102	0.000207	CcSEcCtD
Lisinopril—Rash—Epirubicin—pancreatic cancer	0.000101	0.000206	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—pancreatic cancer	0.000101	0.000206	CcSEcCtD
Lisinopril—Headache—Epirubicin—pancreatic cancer	0.000101	0.000205	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	9.9e-05	0.00822	CbGpPWpGaD
Lisinopril—Dizziness—Doxorubicin—pancreatic cancer	9.84e-05	0.0002	CcSEcCtD
Lisinopril—Nausea—Epirubicin—pancreatic cancer	9.55e-05	0.000194	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—pancreatic cancer	9.46e-05	0.000193	CcSEcCtD
Lisinopril—Rash—Doxorubicin—pancreatic cancer	9.38e-05	0.000191	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—pancreatic cancer	9.37e-05	0.000191	CcSEcCtD
Lisinopril—Headache—Doxorubicin—pancreatic cancer	9.32e-05	0.00019	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	8.96e-05	0.00744	CbGpPWpGaD
Lisinopril—Nausea—Doxorubicin—pancreatic cancer	8.84e-05	0.00018	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	7.24e-05	0.00601	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP2—pancreatic cancer	6.9e-05	0.00573	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	6.51e-05	0.0054	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	6.15e-05	0.0051	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	6.13e-05	0.00509	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GCG—pancreatic cancer	5.86e-05	0.00486	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—pancreatic cancer	5.73e-05	0.00476	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	5.52e-05	0.00458	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CTNNB1—pancreatic cancer	5.29e-05	0.00439	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	5.24e-05	0.00435	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.03e-05	0.00417	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	5.01e-05	0.00416	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	4.59e-05	0.00381	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	4.5e-05	0.00374	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	4.11e-05	0.00342	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	4.06e-05	0.00337	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	3.55e-05	0.00295	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	3.49e-05	0.0029	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	3.08e-05	0.00256	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—pancreatic cancer	3.08e-05	0.00256	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.99e-05	0.00248	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	2.82e-05	0.00234	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	2.7e-05	0.00224	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	2.69e-05	0.00224	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	2.64e-05	0.00219	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.62e-05	0.00217	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	2.57e-05	0.00213	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—pancreatic cancer	2.56e-05	0.00213	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.36e-05	0.00196	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.29e-05	0.0019	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.1e-05	0.00174	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.96e-05	0.00163	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.95e-05	0.00162	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.87e-05	0.00155	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.7e-05	0.00141	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.68e-05	0.0014	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.43e-05	0.00119	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.4e-05	0.00116	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.33e-05	0.0011	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.29e-05	0.00107	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.28e-05	0.00106	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.25e-05	0.00104	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ARG2—pancreatic cancer	1.21e-05	0.00101	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.16e-05	0.000962	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.13e-05	0.000937	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMP—pancreatic cancer	1.06e-05	0.000878	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.04e-05	0.000862	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.04e-05	0.00086	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.02e-05	0.000843	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.67e-06	0.000803	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.59e-06	0.000797	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.81e-06	0.000732	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLP1R—pancreatic cancer	8.53e-06	0.000708	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.53e-06	0.000708	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—DPYD—pancreatic cancer	8.39e-06	0.000697	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A2—pancreatic cancer	7.96e-06	0.000661	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.2e-06	0.000598	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD44—pancreatic cancer	6.17e-06	0.000512	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCG—pancreatic cancer	5.91e-06	0.000491	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STK11—pancreatic cancer	5.56e-06	0.000461	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TYMS—pancreatic cancer	4.78e-06	0.000397	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—pancreatic cancer	3.89e-06	0.000323	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.51e-06	0.000291	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—pancreatic cancer	3.39e-06	0.000281	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.09e-06	0.000256	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.69e-06	0.000223	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.66e-06	0.000221	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTEN—pancreatic cancer	2.32e-06	0.000193	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.64e-06	0.000136	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—pancreatic cancer	1.34e-06	0.000111	CbGpPWpGaD
